CoChat
Sign Up
Cited by 62

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Artificial Intelligence: Exploring the Future of Innovation in Allergy Immunology

MacMath, Derek, Chen, Meng, Khoury, Paneez·2023·Current Allergy and Asthma Reports
DOI 10.1007/s11882-023-01084-zPMC PMC10169188
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11882-023-01084-z

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 82

  1. Lopez-Jimenez F, Attia Z, Arruda-Olson AM, Carter R, Chareonthaitawee P, Jouni H, et al. Artificial intelligence in cardiology: present and future. Mayo Clin Proc. 2020;95(5):1015–39. · DOI
  2. •• Rider NL, Srinivasan R, Khoury P. Artificial intelligence and the hunt for immunological disorders. Curr Opin Allergy Clin Immunol. 2020;20(6). Review highlighting artificial intelligence applications in clinical immunology. · DOI
  3. Ferrante G, Licari A, Fasola S, Marseglia GL, La Grutta S. Artificial intelligence in the diagnosis of pediatric allergic diseases. Pediatr Allergy Immunol. 2021;32(3):405–13. · DOI
  4. Rudrapatna VA, Butte AJ. Opportunities and challenges in using real-world data for health care. J Clin Invest. 2020;130(2):565–74. · DOI
  5. Khoury P, Srinivasan R, Kakumanu S, Ochoa S, Keswani A, Sparks R, et al. A framework for augmented intelligence in allergy and immunology practice and research-a work group report of the AAAAI health informatics, technology, and education committee. J Allergy Clin Immunol Pract. 2022;10(5):1178–88. · DOI
  6. • Sagheb E, Wi C-I, Yoon J, Seol HY, Shrestha P, Ryu E, et al. Artificial intelligence assesses clinicians’ adherence to asthma guidelines using electronic health records. J Allergy Clin Immunol Pract. 2022 Apr;10(4):1047–1056.e1. Demonstration of the use of NLP to assess clinician adherence to asthma guidelines in a retrospective cross-sectional study evaluating 1039 clinical notes for 300 patients with an asthma diagnosis. · DOI
  7. Joumaa H, Sigogne R, Maravic M, Perray L, Bourdin A, Roche N. Artificial intelligence to differentiate asthma from COPD in medico-administrative databases. BMC Pulm Med. 2022;22(1):357. · DOI
  8. Kaplan A, Cao H, FitzGerald JM, Iannotti N, Yang E, Kocks JWH, et al. Artificial intelligence/machine learning in respiratory medicine and potential role in asthma and COPD diagnosis. J Allergy Clin Immunol Pract. 2021;9(6):2255–61. · DOI
  9. Hurst JH, Zhao C, Hostetler HP, Ghiasi Gorveh M, Lang JE, Goldstein BA. Environmental and clinical data utility in pediatric asthma exacerbation risk prediction models. BMC Med Inform Decis Mak. 2022;22(1):108. · DOI
  10. Jiao T, Schnitzer ME, Forget A, Blais L. Identifying asthma patients at high risk of exacerbation in a routine visit: a machine learning model. Respir Med. 2022;198: 106866. · DOI
  11. Inselman JW, Jeffery MM, Maddux JT, Lam RW, Shah ND, Rank MA, et al. A prediction model for asthma exacerbations after stopping asthma biologics. Ann Allergy Asthma Immunol. 2022 Dec 9. · DOI
  12. D’Amato M, Ambrosino P, Simioli F, Adamo S, Stanziola AA, D’Addio G, et al. A machine learning approach to characterize patients with asthma exacerbation attending an acute care setting. Eur J Intern Med. 2022;104:66–72. · DOI
  13. Lugogo NL, DePietro M, Reich M, Merchant R, Chrystyn H, Pleasants R, et al. A predictive machine learning tool for asthma exacerbations: results from a 12-week, open-label study using an electronic multi-dose dry powder inhaler with integrated sensors. J Asthma Allergy. 2022;11(15):1623–37. · DOI
  14. Tsang KCH, Pinnock H, Wilson AM, Salvi D, Shah SA. Predicting asthma attacks using connected mobile devices and machine learning: the AAMOS-00 observational study protocol. BMJ Open. 2022;12(10): e064166. · DOI
  15. Bae WD, Alkobaisi S, Horak M, Park C-S, Kim S, Davidson J. Predicting health risks of adult asthmatics susceptible to indoor air quality using improved logistic and quantile regression models. Life (Basel). 2022 Oct 18;12(10). · DOI
  16. Ray A, Das J, Wenzel SE. Determining asthma endotypes and outcomes: complementing existing clinical practice with modern machine learning. Cell Rep Med. 2022;3(12): 100857. · DOI
  17. Bose S, Kenyon CC, Masino AJ. Personalized prediction of early childhood asthma persistence: a machine learning approach. PLoS ONE. 2021;16(3): e0247784. · DOI
  18. Iqbal FM, Lam K, Joshi M, Khan S, Ashrafian H, Darzi A. Clinical outcomes of digital sensor alerting systems in remote monitoring: a systematic review and meta-analysis. npj Digital Med. 2021 Jan 8;4(1):7. · DOI
  19. Eikholt AA, Wiertz MBR, Hew M, Chan AHY, van Boven JFM. Electronic monitoring devices to support inhalation technique in patients with asthma: a narrative review. Curr Treat Options Allergy. 2023 Feb 17. · DOI
  20. Duverdier A, Custovic A, Tanaka RJ. Data-driven research on eczema: systematic characterization of the field and recommendations for the future. Clin Transl Allergy. 2022;12(6): e12170. · DOI
  21. De A, Sarda A, Gupta S, Das S. Use of artificial intelligence in dermatology. Indian J Dermatol. 2020;65(5):352–7. · DOI
  22. Eyerich K, Brown SJ, Perez White BE, Tanaka RJ, Bissonette R, Dhar S, et al. Human and computational models of atopic dermatitis: a review and perspectives by an expert panel of the International Eczema Council. J Allergy Clin Immunol. 2019;143(1):36–45. · DOI
  23. Aggarwal SLP. Data augmentation in dermatology image recognition using machine learning. Skin Res Technol. 2019;25(6):815–20. · DOI
  24. Rasheed A, Umar AI, Shirazi SH, Khan Z, Nawaz S, Shahzad M. Automatic eczema classification in clinical images based on hybrid deep neural network. Comput Biol Med. 2022;147: 105807. · DOI
  25. Guimarães P, Batista A, Zieger M, Kaatz M, Koenig K. Artificial intelligence in multiphoton tomography: atopic dermatitis diagnosis. Sci Rep. 2020;10(1):7968. · DOI
  26. Park S, Saw SN, Li X, Paknezhad M, Coppola D, Dinish US, et al. Model learning analysis of 3D optoacoustic mesoscopy images for the classification of atopic dermatitis. Biomed Opt Express. 2021;12(6):3671–83. · DOI
  27. Aguirre J, Schwarz M, Garzorz N, Omar M, Buehler A, Eyerich K, et al. Precision assessment of label-free psoriasis biomarkers with ultra-broadband optoacoustic mesoscopy. Nat Biomed Eng. 2017;1(5):0068. · DOI
  28. Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013;132(6):1337–47. · DOI
  29. Medela A, Mac Carthy T, Aguilar Robles SA, Chiesa-Estomba CM, Grimalt R. Automatic scoring of atopic dermatitis using deep learning: a pilot study. JID Innov. 2022;2(3): 100107. · DOI
  30. Hurault G, Domínguez-Hüttinger E, Langan SM, Williams HC, Tanaka RJ. Personalized prediction of daily eczema severity scores using a mechanistic machine learning model. Clin Exp Allergy. 2020;50(11):1258–66. · DOI
  31. Hurault G, Stalder JF, Mery S, Delarue A, Saint Aroman M, Josse G, et al. EczemaPred: A computational framework for personalised prediction of eczema severity dynamics. Clin Transl Allergy. 2022;12(3): e12140. · DOI
  32. Holm JG, Hurault G, Agner T, Clausen ML, Kezic S, Tanaka RJ, et al. Immunoinflammatory biomarkers in serum are associated with disease severity in atopic dermatitis. Dermatology (Basel). 2021;237(4):513–20. · DOI
  33. Maintz L, Welchowski T, Herrmann N, Brauer J, Kläschen AS, Fimmers R, et al. Machine learning-based deep phenotyping of atopic dermatitis: severity-associated factors in adolescent and adult patients. JAMA Dermatol. 2021;157(12):1414–24. · DOI
  34. Clayton K, Vallejo A, Sirvent S, Davies J, Porter G, Reading IC, et al. Machine learning applied to atopic dermatitis transcriptome reveals distinct therapy-dependent modification of the keratinocyte immunophenotype. Br J Dermatol. 2021;184(5):913–22. · DOI · Paper page
  35. Acharjee A, Gribaleva E, Bano S, Gkoutos GV. Multi-omics-based identification of atopic dermatitis target genes and their potential associations with metabolites and miRNAs. Am J Transl Res. 2021;13(12):13697–709.
  36. Zeldin J, Chaudhary PP, Spathies J, Yadav M, D’Souza BN, Alishahedani ME, et al. Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteria. Sci Adv. 2023 Jan 6;9(1):eade8898. · DOI
  37. Hurault G, Roekevisch E, Schram ME, Szegedi K, Kezic S, Middelkamp-Hup MA, et al. Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients? Skin Health and Disease. 2022;2(1): e77. · DOI
  38. Wu JJ, Hong C-H, Merola JF, Gruben D, Güler E, Feeney C, et al. Predictors of nonresponse to dupilumab in patients with atopic dermatitis: a machine learning analysis. Ann Allergy Asthma Immunol. 2022;129(3):354-359.e5. · DOI
  39. Huang J, Habib AR, Mendis D, Chong J, Smith M, Duvnjak M, et al. An artificial intelligence algorithm that differentiates anterior ethmoidal artery location on sinus computed tomography scans. J Laryngol Otol. 2020;134(1):52–5. · DOI
  40. Parmar P, Habib AR, Mendis D, Daniel A, Duvnjak M, Ho J, et al. An artificial intelligence algorithm that identifies middle turbinate pneumatisation (concha bullosa) on sinus computed tomography scans. J Laryngol Otol. 2020;134(4):328–31. · DOI
  41. Jeon Y, Lee K, Sunwoo L, Choi D, Oh DY, Lee KJ, et al. Deep learning for diagnosis of paranasal sinusitis using multi-view radiographs. Diagnostics (Basel). 2021 Feb 5;11(2). · DOI
  42. Murata M, Ariji Y, Ohashi Y, Kawai T, Fukuda M, Funakoshi T, et al. Deep-learning classification using convolutional neural network for evaluation of maxillary sinusitis on panoramic radiography. Oral Radiol. 2019;35(3):301–7. · DOI
  43. Grayson JW, Hopkins C, Mori E, Senior B, Harvey RJ. Contemporary classification of chronic rhinosinusitis beyond polyps vs no polyps: a review. JAMA Otolaryngol Head Neck Surg. 2020;146(9):831–8. · DOI
  44. • Zhou H, Fan W, Qin D, Liu P, Gao Z, Lv H, et al. Development, validation and comparison of artificial neural network and logistic regression models predicting eosinophilic chronic rhinosinusitis with nasal polyps. Allergy Asthma Immunol Res. 2023 Jan;15(1):67–82. ANN models to predict eosinophilic CRSwNP based on clinical biomarkers in 109 CRSwNP patients outperformed logistic regression models. · DOI
  45. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy. 2014;69(4):420–37. · DOI
  46. Park M, Markus P, Matesic D, Li JTC. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol. 2006;97(5):681–7. · DOI
  47. Blumenthal KG, Oreskovic NM, Fu X, Shebl FM, Mancini CM, Maniates JM, et al. High-cost, high-need patients: the impact of reported penicillin allergy. Am J Manag Care. 2020;26(4):154–61. · DOI
  48. Inglis JM, Bacchi S, Troelnikov A, Smith W, Shakib S. Automation of penicillin adverse drug reaction categorisation and risk stratification with machine learning natural language processing. Int J Med Inform. 2021;156: 104611. · DOI
  49. Moreno EM, Moreno V, Laffond E, Gracia-Bara MT, Muñoz-Bellido FJ, Macías EM, et al. Usefulness of an artificial neural network in the prediction of β-lactam allergy. J Allergy Clin Immunol Pract. 2020;8(9):2974-2982.e1. · DOI
  50. • Banerji A, Lai KH, Li Y, Saff RR, Camargo CA, Blumenthal KG, et al. Natural language processing combined with ICD-9-CM codes as a novel method to study the epidemiology of allergic drug reactions. J Allergy Clin Immunol Pract. 2020;8(3):1032–1038.e1. Highlights the potential for NLP utilization in epidemiologic evaluation of drug allergy by showing how NLP increases the PPV of ICD code review in identifying true cases of drug allergy. · DOI
  51. Chaichulee S, Promchai C, Kaewkomon T, Kongkamol C, Ingviya T, Sangsupawanich P. Multi-label classification of symptom terms from free-text bilingual adverse drug reaction reports using natural language processing. PLoS One. 2022;17(8): e0270595. · DOI
  52. Lo Y-C, Varghese S, Blackley S, Seger DL, Blumenthal KG, Goss FR, et al. Reconciling allergy information in the electronic health record after a drug challenge using natural language processing. FrontAllergy. 2022;10(3): 904923.
  53. Blanca-Lopez N, Somoza-Alvarez ML, Bellon T, Amo G, Canto G, Blanca M. NSAIDs hypersensitivity: questions not resolved. Curr Opin Allergy Clin Immunol. 2018;18(4):291–301. · DOI
  54. Tyrak KE, Pajdzik K, Konduracka E, Ćmiel A, Jakieła B, Celejewska-Wójcik N, et al. Artificial neural network identifies nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD) cohort. Allergy. 2020;75(7):1649–58. · DOI
  55. Tay SH, Santosa A, Goh ECH, Xu CX, Wu LH, Bigliardi-Qi M, et al. Distinct transcriptomic and metabolomic profiles characterize NSAID-induced urticaria/angioedema patients undergoing aspirin desensitization. J Allergy Clin Immunol. 2022;150(6):1486–97. · DOI
  56. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010 Oct;105(4):259–73. · DOI
  57. Abrams EM, Greenhawt M, Shaker M, Kosowan L, Singer AG. Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada. Ann Allergy Asthma Immunol. 2021;127(4):446-450.e1. · DOI
  58. Abbaspour S, Robbins GK, Blumenthal KG, Hashimoto D, Hopcia K, Mukerji SS, et al. Identifying modifiable predictors of COVID-19 vaccine side effects: a machine learning approach. Vaccines (Basel). 2022 Oct 19;10(10). · DOI
  59. Flora J, Khan W, Jin J, Jin D, Hussain A, Dajani K, et al. Usefulness of vaccine adverse event reporting system for machine-learning based vaccine research: a case study for COVID-19 vaccines. Int J Mol Sci. 2022 Jul 26;23(15). · DOI
  60. Patel JS, Zhan S, Siddiqui Z, Dzomba B, Wu H. Automatic identification of self-reported COVID-19 vaccine information from vaccine adverse events reporting system. Methods Inf Med. 2023 Jan 9. · DOI
  61. Khalid MB, Frischmeyer-Guerrerio PA. The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis. J Allergy Clin Immunol Glob. 2023;2(1):1–13. · DOI
  62. Metwally AA, Yu PS, Reiman D, Dai Y, Finn PW, Perkins DL. Utilizing longitudinal microbiome taxonomic profiles to predict food allergy via long short-term memory networks. PLoS Comput Biol. 2019;15(2): e1006693. · DOI
  63. Suprun M, Sicherer SH, Wood RA, Jones SM, Leung DYM, Henning AK, et al. Early epitope-specific IgE antibodies are predictive of childhood peanut allergy. J Allergy Clin Immunol. 2020;146(5):1080–8. · DOI
  64. • Grinek S, Suprun M, Raghunathan R, Tomalin LE, Getts R, Bahnson T, et al. Epitope-specific IgE at 1 year of age can predict peanut allergy status at 5 years. Int Arch Allergy Immunol. 2022 Dec 9;1–6. Utilization of elastic net regression ML model trained on demographics, total IgE, IgE to egg white, egg yolk, and ovomucoid from pediatric patients in the peanut avoidance arm of LEAP trial at 1 year to predict heated egg OFC success at 5 years with 83% accuracy. · DOI
  65. Kuniyoshi Y, Tokutake H, Takahashi N, Kamura A, Yasuda S, Tashiro M. Machine learning approach and oral food challenge with heated egg. Pediatr Allergy Immunol. 2021;32(4):776–8. · DOI · Paper page
  66. Machnes-Maayan D, Yahia SH, Frizinsky S, Maoz-Segal R, Offengenden I, Kenett RS, et al. A clinical pathway for the diagnosis of sesame allergy in children. World Allergy Organiz J. 2022;15(11): 100713. · DOI
  67. Suárez-Fariñas M, Suprun M, Chang HL, Gimenez G, Grishina G, Getts R, et al. Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles. J Allergy Clin Immunol. 2019;143(3):1038–46. · DOI
  68. Bann MA, Carrell DS, Gruber S, Shinde M, Ball R, Nelson JC, et al. Identification and validation of anaphylaxis using electronic health data in a population-based setting. Epidemiology. 2021;32(3):439–43. · DOI
  69. Carrell DS, Gruber S, Floyd JS, Bann MA, Cushing-Haugen KL, Johnson RL, et al. Improving methods of identifying anaphylaxis for medical product safety surveillance using natural language processing and machine learning. Am J Epidemiol. 2023;192(2):283–95. · DOI
  70. Garcia-Moreno FM, Gutiérrez-Naranjo MA. ALLERDET: a novel web app for prediction of protein allergenicity. J Biomed Inform. 2022;135: 104217. · DOI
  71. Segú-Vergés C, Gómez J, Terradas-Montana P, Artigas L, Smeets S, Ferrer M, et al. Unveiling chronic spontaneous urticaria pathophysiology through systems biology. J Allergy Clin Immunol. 2022 Dec 29. · DOI
  72. Pivneva I, Balp M-M, Geissbühler Y, Severin T, Smeets S, Signorovitch J, et al. Predicting clinical remission of chronic urticaria using random survival forests: machine learning applied to real-world data. Dermatol Ther (Heidelb). 2022;12(12):2747–63. · DOI
  73. Sardina DS, Valenti G, Papia F, Uasuf CG. Exploring machine learning techniques to predict the response to omalizumab in chronic spontaneous urticaria. Diagnostics (Basel). 2021 Nov 20;11(11). · DOI
  74. Sallis BF, Erkert L, Moñino-Romero S, Acar U, Wu R, Konnikova L, et al. An algorithm for the classification of mRNA patterns in eosinophilic esophagitis: integration of machine learning. J Allergy Clin Immunol. 2018;141(4):1354-1364.e9. · DOI
  75. Okimoto E, Ishimura N, Adachi K, Kinoshita Y, Ishihara S, Tada T. Application of convolutional neural networks for diagnosis of eosinophilic esophagitis based on endoscopic imaging. J Clin Med. 2022 Apr 30;11(9). · DOI
  76. Czyzewski T, Daniel N, Rochman M, Caldwell JM, Osswald GA, Collins MH, et al. Machine learning approach for biopsy-based identification of eosinophilic esophagitis reveals importance of global features. IEEE Open J Eng Med Biol. 2021;16(2):218–23. · DOI
  77. Archila LR, Smith L, Sihvo H-K, Westerling-Bui T, Koponen V, O’Sullivan DM, et al. Development and technical validation of an artificial intelligence model for quantitative analysis of histopathologic features of eosinophilic esophagitis. J Pathol Inform. 2022;27(13): 100144. · DOI
  78. Larey A, Aknin E, Daniel N, Osswald GA, Caldwell JM, Rochman M, et al. Harnessing artificial intelligence to infer novel spatial biomarkers for the diagnosis of eosinophilic esophagitis. arXiv. 2022 May 26. · DOI
  79. Celi LA, Cellini J, Charpignon M-L, Dee EC, Dernoncourt F, Eber R, et al. Sources of bias in artificial intelligence that perpetuate healthcare disparities-a global review. PLOS Digit Health. 2022;1(3): e0000022. · DOI · Paper page
  80. McCradden MD, Joshi S, Mazwi M, Anderson JA. Ethical limitations of algorithmic fairness solutions in health care machine learning. Lancet Digit Health. 2020;2(5):e221–3. · DOI · Paper page
  81. Reddy S, Fox J, Purohit MP. Artificial intelligence-enabled healthcare delivery. J R Soc Med. 2019;112(1):22–8. · DOI · Paper page
  82. • Vollmer S, Mateen BA, Bohner G, Király FJ, Ghani R, Jonsson P, et al. Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness. BMJ. 2020 Mar 20;368:l6927. Proposes a framework for investigators using machine learning to ensure that AI tools in medicine are safe and effective. · DOI

Cited by

Sorted by citations

See all 62

Metadata

Authors
MacMath, D., Chen, M., & Khoury, P.
ORCID
Khoury, Paneez
Venue
Current Allergy and Asthma Reports
Publisher
Springer Science and Business Media LLC
Published
2023-05-09
Volume
23
Issue
6
Pages
351-362
ISSN
  • 1529-7322
  • 1534-6315
DOI
10.1007/s11882-023-01084-z
PMC
PMC10169188
Cited by
62
References
17
Language
en
Licence
Funders
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases (1ZIEAI001148-11)
  • National Institute of Allergy and Infectious Diseases (5R25AI147369-03)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Artificial Intelligence: Exploring the Future of Innovation in Allergy Immunology. https://app.cochat.ai/papers/10.1007/s11882-023-01084-z
The paper
MacMath, D., Chen, M., & Khoury, P. (2023). Artificial Intelligence: Exploring the Future of Innovation in Allergy Immunology. Current Allergy and Asthma Reports. https://doi.org/10.1007/s11882-023-01084-z